Broadfin Capital

Ticker	# of Shares	Price	Value
	5,574,366	$195.32	$1,088,785,168
	2,707,851	$195.32	$528,897,458
	2,000,000	$195.32	$390,640,000
	1,839,372	$195.32	$359,266,140
SPY	440,000	$733.58	$322,775,200
	1,236,368	$195.32	$241,487,398
IWM	800,000	$295.32	$236,256,000
	1,029,012	$195.32	$200,986,624
	1,003,099	$195.32	$195,925,297
	721,073	$195.32	$140,839,979
View Additional Portfolio Information »

Broadfin Capital

Mar 20, 2018 04:43PM Form SC 13D/A NOVELION THERAPEUTICS Filed by: Broadfin Capital, LLC
Mar 15, 2018 05:17PM Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 15, 2018 05:17PM Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 15, 2018 05:10PM Novelion Therapeutics Subsidiary Enters into $20 Million Term Loan Agreement with Sarissa Capital and Broadfin Capital
Mar 15, 2018 05:10PM Novelion Therapeutics Subsidiary Enters into $20 Million Term Loan Agreement with Sarissa Capital and Broadfin Capital

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)